OXIS INTERNATIONAL Chart calendar Oxis International
c33d39d70a1d.Sxe6PysOFjsZEoxO8Reze9ejVHycEmZSdZkdBgAhROM.Jmf4Ck9hQ3N0K-IEwlvHNbbUNy74ZhMQTfV1azEYfK0OSMB1GFtGdUpczQ~65a87b66201ab19a61d9a96a18a60f5b
Upcoming events on Oxis International
Past events on Oxis International
| 16/05/2024 02:30 am | Q1 2024 Earnings Release |
| 19/12/2023 12:30 am | Extraordinary Shareholders Meeting |
| 05/11/2023 07:30 am | Society for Immunotherapy of Cancer Meeting - Abstract No:1180 |
| 05/11/2023 12:25 am | Society for Immunotherapy of Cancer Meeting - Abstract No:1180 |
| 01/11/2023 06:30 pm | Q3 2023 Earnings Release |
| 18/08/2023 01:00 am | H.C. Wainwright Immune Cell Engager Conference |
| 07/08/2023 06:30 pm | Q2 2023 Earnings Release |
| 28/06/2023 11:30 pm | Annual General Meeting |
| 25/05/2023 | ASTCT EBMT Joint Basic and Translational Scientific Meeting |
| 16/05/2023 06:30 pm | PEGS Boston Conference |
| 16/05/2023 02:30 am | Q1 2023 Earnings Release |
| 31/03/2023 02:30 am | Q4 2022 Earnings Release |
| 28/02/2023 07:30 pm | H.C. Wainwright Cell Therapy Virtual Conference |
| 13/12/2022 04:30 am | American Society of Hematology Meeting - Abstract Number: 4623 |
| 11/11/2022 07:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1204 |
| 11/11/2022 07:30 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1202 |
| 01/11/2022 02:45 am | Q3 2022 Earnings Release |
| 27/10/2022 05:00 am | LD Micro Main Event Conference |
| 10/10/2022 11:30 pm | Extraordinary Shareholders Meeting |
| 28/09/2022 | Extraordinary Shareholders Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -6,76 -6,10 -10.89% | -57,5 -46,2 -24.59% | -21,3 -21,2 -0.2% | -13,6 -13,9 2.65% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -28,3 -16,9 -67.12% | -58,0 -46,6 -24.61% | -20,9 -21,5 2.87% | -7,60 -8,17 7.04% |
|
Net income Million USD | Released Forecast Spread | -38,6 | -28,3 -16,9 -67.12% | -58,0 -46,3 -25.2% | -20,9 -21,5 3% | -7,60 -8,17 7.04% |
|
EPS USD | Released Forecast Spread | -342 | -194 -6,75 -2766.67% | -61,8 -49,4 -25.1% | -19,8 -20,1 1.49% | -5,64 -6,00 6% |
| Announcement Date | 27/03/20 | 16/04/21 | 28/03/22 | 30/03/23 | 26/03/24 |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -5,44 -7,45 26.95% | -3,01 -5,96 49.4% | -7,02 -3,83 -83.15% | -5,78 -5,73 -0.93% | -3,67 -5,70 35.7% | -3,62 -4,15 12.75% | -3,12 -3,95 20.96% | -3,17 -3,54 10.43% | -3,09 -3,88 20.38% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,44 -7,33 25.82% | -2,98 -5,93 49.76% | -6,88 -3,77 -82.4% | -5,58 -6,23 10.35% | -0,23 -6,00 96.22% | -1,99 -4,10 51.41% | -2,42 -3,95 38.84% | -2,96 -3,54 16.26% | -2,27 -3,88 41.63% |
|
Net income Million USD | Released Forecast Spread | -5,44 -7,33 25.82% | -2,98 -5,93 49.76% | -6,88 -3,77 -82.4% | -5,58 -6,23 10.35% | -0,23 -6,00 96.22% | -1,99 -4,10 51.41% | -2,42 -3,95 38.84% | -2,96 -3,54 16.26% | -2,27 -3,88 41.63% |
|
EPS USD | Released Forecast Spread | -5,10 -6,90 26.09% | -3,00 -5,40 44.44% | -6,60 -3,30 -100% | -5,40 -5,70 5.26% | -0,30 -4,80 93.75% | -1,50 -3,00 50% | -1,80 -3,00 40% | -5,52 -2,70 -104.44% | -1,64 -2,70 39.26% |
| Announcement Date | 16/05/22 | 15/08/22 | 31/10/22 | 30/03/23 | 15/05/23 | 07/08/23 | 01/11/23 | 26/03/24 | 15/05/24 |
| 30/05/2024 | MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 | SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 30/05/2024 04:30 pm | ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release |
| 04/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
| 11/07/2024 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release (Projected) |
| 16/07/2024 | JOHNSON & JOHNSON: Q2 2024 Earnings Release (Projected) |
| 16/07/2024 | CAMURUS AB: Q2 2024 Earnings Release |
| 17/07/2024 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
| 18/07/2024 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
| 18/07/2024 10:30 am | NOVARTIS AG: Q2 2024 Earnings Release |
